Pharma Reviews: Price accounts for 55% of FY20 pharma growth, hits a five-year high

For the first time in at least five years, price is the key factor driving the Rs 1.4 trillion Indian pharmaceutical market (IPM). For FY20, price accounted for ...
Read more: Price accounts for 55% of FY20 pharma growth, hits a five-year high